Verition Fund Management LLC Pfizer Inc Transaction History

Verition Fund Management LLC

$21.7 Billion
Q3 2025

A detailed history of Verition Fund Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 365,892 shares of PFE stock, worth $9.18 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

365,892

Previous 319,376 14.56%

Holding current value

$9.18 Million

Previous $7.74 Million 20.42%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$23.29 - $25.88 $1.08 Million - $1.2 Million	46,516 Added 14.56%	365,892 $9.32 Million
Q2 2025 Aug 14, 2025	SELL	$21.59 - $24.84 $712,297 - $819,521	-32,992 Reduced 9.36%	319,376 $7.74 Million
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $6.22 Million - $6.74 Million	248,509 Added 239.28%	352,368 $8.93 Million
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $1.74 Million - $2.12 Million	-70,086 Reduced 40.29%	103,859 $2.76 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $1.36 Million - $1.54 Million	49,011 Added 39.23%	173,945 $5.03 Million

Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $15,939 - $18,677	-631 Reduced 0.5%	124,934 $3.5 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $563,418 - $646,984	-21,762 Reduced 14.77%	125,565 $3.48 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $361,090 - $469,016	13,819 Added 10.35%	147,327 $4.24 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.16 Million - $1.35 Million	36,039 Added 36.97%	133,508 $4.43 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $332,845 - $385,094	9,215 Added 10.44%	97,469 $3.58 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $578,599 - $753,251	14,689 Added 19.97%	88,254 $3.6 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $3.34 Million - $4.36 Million	-79,966 Reduced 52.08%	73,565 $3.77 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $4.52 Million - $5.52 Million	103,397 Added 206.24%	153,531 $6.72 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $48,298 - $57,266	-1,038 Reduced 2.03%	50,134 $2.63 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $2.14 Million - $2.65 Million	46,672 Added 1037.16%	51,172 $2.65 Million
Q4 2021 May 03, 2022	SELL	$41.32 - $61.25 $37,518 - $55,615	-908 Reduced 16.79%	4,500 $266,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $678,598 - $1.01 Million	-16,423 Reduced 75.23%	5,408 $319,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $184,121 - $236,520	4,691 Added 27.37%	21,831 $939,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $227,741 - $257,992	-6,342 Reduced 27.01%	17,140 $671,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $375,801 - $477,863	11,228 Added 91.63%	23,482 $864,000
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $1.94 Million - $2.28 Million	-61,174 Reduced 83.31%	12,254 $450,000
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $2.21 Million - $2.68 Million	73,428 New	73,428 $2.4 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $1.47 Million - $2.1 Million	-54,317 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $1.13 Million - $1.29 Million	34,455 Added 173.47%	54,317 $2.13 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $313,788 - $406,891	-9,658 Reduced 32.72%	19,862 $714,000
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $1.09 Million - $1.23 Million	29,520 New	29,520 $1.28 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $927,243 - $1.12 Million	-26,900 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $62,661 - $66,804	-1,900 Reduced 6.6%	26,900 $976,000
Q1 2018 May 16, 2018	BUY	$31.91 - $37.02 $919,008 - $1.07 Million	28,800 New	28,800 $1.02 Million

Others Institutions Holding PFE

# of Institutions

3,355

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Pfizer Inc Transaction History